FUMAGALLI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 12.321
NA - Nord America 3.583
AS - Asia 2.577
SA - Sud America 263
AF - Africa 61
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.830
Nazione #
IT - Italia 9.412
US - Stati Uniti d'America 3.513
RU - Federazione Russa 1.111
SG - Singapore 781
CN - Cina 698
NL - Olanda 537
HK - Hong Kong 299
KR - Corea 225
IE - Irlanda 221
BR - Brasile 204
VN - Vietnam 201
SE - Svezia 161
FR - Francia 157
DE - Germania 140
CH - Svizzera 125
GB - Regno Unito 106
PL - Polonia 97
FI - Finlandia 88
IN - India 88
JO - Giordania 46
TR - Turchia 45
CA - Canada 33
ES - Italia 33
BD - Bangladesh 31
AR - Argentina 27
ID - Indonesia 26
AU - Australia 24
JP - Giappone 24
MX - Messico 24
IQ - Iraq 15
UA - Ucraina 15
AT - Austria 13
BE - Belgio 13
DK - Danimarca 12
EC - Ecuador 12
TH - Thailandia 12
AE - Emirati Arabi Uniti 11
PK - Pakistan 11
SA - Arabia Saudita 11
RO - Romania 10
ZA - Sudafrica 10
LT - Lituania 9
RS - Serbia 9
MA - Marocco 8
CZ - Repubblica Ceca 7
EG - Egitto 7
IR - Iran 7
NG - Nigeria 7
CI - Costa d'Avorio 6
NO - Norvegia 6
TW - Taiwan 6
BJ - Benin 5
CL - Cile 5
CO - Colombia 5
GR - Grecia 5
UZ - Uzbekistan 5
BG - Bulgaria 4
MD - Moldavia 4
MT - Malta 4
MY - Malesia 4
PT - Portogallo 4
TN - Tunisia 4
DZ - Algeria 3
GH - Ghana 3
IL - Israele 3
JM - Giamaica 3
LV - Lettonia 3
MM - Myanmar 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
SI - Slovenia 3
SM - San Marino 3
VE - Venezuela 3
AZ - Azerbaigian 2
BY - Bielorussia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MG - Madagascar 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
Totale 18.823
Città #
Milan 1.048
Santa Clara 938
Rome 827
Ashburn 655
Singapore 592
Florence 274
Hong Kong 258
Turin 231
Seoul 225
Bologna 212
Dublin 212
Hefei 210
San Jose 182
Naples 175
Chandler 136
Verona 126
Fairfield 118
Beijing 111
Bari 103
Genoa 103
Palermo 85
Dallas 78
Los Angeles 77
Ho Chi Minh City 72
Moscow 71
Padova 69
Modena 66
Warsaw 64
Munich 63
Brescia 59
Lawrence 58
New York 58
Altamura 57
Venice 56
Catania 49
Lauterbourg 48
Hanoi 45
Rimini 45
Houston 44
Livorno 42
Monza 41
Woodbridge 41
Buffalo 40
Helsinki 40
Wilmington 40
Cambridge 39
Seattle 38
Boston 37
Perugia 37
Council Bluffs 36
Mumbai 35
Princeton 35
Parma 34
Cagliari 32
Turku 32
Zurich 32
Vicenza 31
The Dalles 30
Trento 30
Bern 29
Kent 29
Shanghai 29
São Paulo 29
Trieste 29
Prato 28
Frankfurt am Main 27
London 26
Padua 26
Pescara 26
Reggio Emilia 25
Bergamo 24
Jakarta 24
Tokyo 22
Hangzhou 21
Lucca 21
Melbourne 20
Orem 20
Messina 19
San Diego 19
Treviso 19
Taranto 18
Ann Arbor 17
Bolzano 17
Pisa 17
Paris 16
Ancona 15
Cesena 15
Grottaglie 14
Bengaluru 13
Boardman 13
Cologno Monzese 13
Imola 13
Lappeenranta 13
Brooklyn 12
Figino 12
Montesilvano Marina 12
Montreal 12
West Jordan 12
Cantù 11
Chennai 11
Totale 9.410
Nome #
Ascolto di musica a 440 HZ versus musica a 432 HZ per la riduzione dell’ansia covid correlata negli infermieri del 118: un trial pilota randomizzato controllato in doppio cieco 10.105
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 220
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 214
Biometric refractive error after cataract and retina surgery: a systematic review and a benchmark proposal 210
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 205
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 199
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 197
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 196
LA TERAPIA ANTICOAGULANTE ORALE IN PAZIENTI DI ETÀ AVANZATA CON FIBRILLAZIONE ATRIALE È ANCORA POCO UTILIZZATA. UN’ANALISI DEL REGISTRO GEROCOVID DELLA SOCIETÀ ITALIANA DI GERONTOLOGIA E GERIATRIA 196
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 193
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 191
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 190
Ranolazine is associated with a reduced incidence of atrial fibrillation in patients with chronic coronary syndrome: the results of a real-world analysis of an Italian population 184
The Listening to music tuned to 440 Hz versus 432 Hz to reduce anxiety and stress in emergency nurses during the COVID-19 pandemic: a double-blind, randomized controlled pilot study 181
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 176
Correction to: Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy (Journal of Nuclear Cardiology, (2022), 10.1007/s12350-022-02911-y) 169
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): a pilot study 168
Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy 168
P392Preliminary evaluation of stress myocardial blood flow pattern in patients with apical hypertrophic cardiomyopathy candidate to be enrolled in the CARAPACE study 167
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 167
Association of Obesity with Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy 166
Ventricular tachyarrhythmias and sudden cardiac death in light-chain amyloidosis: a clash of cardio-toxicities? 165
Ventricular arterial coupling alteration and long term prognosis in patients with hypertrophic cardiomyopathy 164
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 162
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 162
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 161
Lower extremity performance predicts length of hospital stay in older candidates to elective cardiac surgery 161
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 160
Feasibility of a combined mobile-health electrocardiographic and rapid diagnostic test screening for chagas-related cardiac alterations 159
Prognostic value of cardiopulmonary exercise testing in patients with transthyretin cardiac amyloidosis 156
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 156
P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes 154
Cardiomyopathies in children – inherited heart muscle disease: Overview of hypertrophic, dilated, restrictive and non-compaction phenotypes 154
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 154
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 153
From atrial fibrillation management to atrial myopathy assessment: the evolving concept of left atrium disease in hypertrophic cardiomyopathy 151
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 150
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis 149
Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy 149
EFFETTI DELLA TERAPIA PRE-RICOVERO CON ANTAGONISTI DEL SISTEMA RENINA-ANGIOTENSINA IN PAZIENTI DI ETÀ AVANZATA CON COVID-19. DAL REGISTRO GEROCOVID DELLA SOCIETÀ ITALIANA DI GERONTOLOGIA E GERIATRIA 147
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 146
Telemedicine cardiovascular screening program in low-income settings by smartphone based technology 143
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy 142
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 141
Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist 139
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 139
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 138
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 132
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 132
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 131
Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry 128
The Importance of Sex Differences in Patients with Hypertrophic Cardiomyopathy – Tailoring Management and Future Perspectives 126
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 126
β-blockers: Their new life from hypertension to cancer and migraine 125
Layman electrocardiographic screening using smartphone-based multiple‑lead ECG device in school children 106
International patient preferences for physician attire: results from cross-sectional studies in four countries across three continents 92
null 7
Totale 18.922
Categoria #
all - tutte 40.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.959


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022289 22 6 11 9 15 17 6 23 35 21 52 72
2022/2023898 56 180 51 39 61 152 124 59 99 7 36 34
2023/20241.603 28 52 72 29 62 92 47 147 53 226 359 436
2024/20258.948 1.019 691 614 1.090 1.280 798 556 647 594 527 585 547
2025/20266.725 576 780 644 634 714 287 678 448 296 477 476 715
2026/202783 83 0 0 0 0 0 0 0 0 0 0 0
Totale 18.922